
Targacept and Catalyst Biosciences have signed a merger agreement which will see them develop new treatment options for patients with …
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals

